Prot #PANC003: A Phase III Multicenter Open-Label Randomized Trial to Evaluate Efficacy and Safety of FOLFIRINOX (FFX) versus Combination of CPI-613 with modified FOLFIRINOX (mFFX) in Patients with Metastatic Adenocarcinoma of the Pancreas

Project: Research project

Project Details

StatusFinished
Effective start/end date10/25/19 → 10/25/22

Funding

  • Covance Inc. (Prot #PANC003)
  • Rafael Pharmaceuticals, Inc. (Prot #PANC003)